Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe weight loss injection works by mimicking gut hormones that signal fullness and slow the rate at which your stomach empties. In plain terms: you feel satisfied on less food, cravings quieten, and your body's calorie intake falls — not through willpower, but through biology. These are prescription-only medicines, assessed individually by a prescriber before any treatment begins. There are two main injections licensed in the UK for weight management (tirzepatide (Mounjaro) and semaglutide (Wegovy)) and while they share this general mechanism, they act on slightly different receptors, which matters when your prescriber is deciding which suits you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture a Tuesday evening. You've taken your pen out of the fridge, cleaned the skin on your thigh, pressed the button and heard the click. Within minutes the medicine is absorbed into the tissue beneath the skin. You won't feel it working, there's no rush, no jolt. Over the next several hours, though, tirzepatide or semaglutide begins binding to receptors in the gut and the brain that are normally activated by the hormones GIP and GLP-1, released naturally after you eat.
The practical result: when your next meal comes around, the gastric-emptying signal is slowed. Food moves through your stomach at a reduced rate. You feel fuller faster and stay satisfied longer. The brain's appetite centres also receive a quieter hunger signal, so the background noise of wanting to eat (the mid-afternoon biscuit pull, the extra portion) gradually softens. This isn't suppression in the blunt sense of an appetite suppressant; it's closer to a recalibration of your body's own satiety machinery.
These medicines are injected once weekly because they have a long half-life in the body, maintaining consistent receptor activity rather than peaks and troughs. The full mechanism of the weight loss injection, including how the GIP and GLP-1 pathways differ, is worth reading if you want the detail behind the biology. The NHS patient information page for tirzepatide covers what to expect in accessible, verified terms.
The hormonal signalling effect is fairly immediate, but meaningful weight change takes weeks of consistent lower calorie intake. Clinical trials give the clearest picture of scale. In the SURMOUNT-1 trial (2,539 adults with obesity, running for 72 weeks) participants on the highest tirzepatide dose achieved around 20–21% average body-weight reduction. Whether the weight loss injection works to that degree for any individual depends on adherence, diet, activity and clinical suitability, but the trial evidence is the strongest we have. Semaglutide's STEP 1 trial, similarly structured, showed around 15% average reduction at the 2.4mg maintenance dose over 68 weeks.
Day to day, people typically notice the appetite change before the scale moves. Portions shrink naturally. Foods that were hard to resist become easier to pass on, not because of discipline, but because the desire has genuinely reduced. That shift can feel unfamiliar at first. It also means nutrition matters more, not less: eating less but eating well (enough protein, enough fibre, adequate hydration) is what a prescriber or dietitian would encourage alongside treatment.
The titration schedule (starting at a low dose and increasing gradually) exists precisely because these hormonal changes also affect how quickly your stomach empties, and moving too fast produces the nausea and GI discomfort that some people experience. Starting low is not a delay; it's how the medicine is designed to be used safely. The SURMOUNT-1 paper in the New England Journal of Medicine details the full efficacy and safety data if you want to read primary evidence.
The same mechanism that produces weight loss explains most of the side effects. Slowing gastric emptying can cause nausea, particularly in the early weeks or after a dose increase. Diarrhoea, constipation, burping, and indigestion are all downstream of the same gut-signalling effect. For most people these are mild and settle within a couple of weeks as the body adjusts. They are not a sign something is wrong, they are the expected pharmacology doing its job at a new intensity.
There are rarer effects that warrant prompt attention. Severe, persistent stomach pain that radiates to the back (with or without vomiting) should be assessed urgently, as this can be a sign of pancreatitis. The MHRA highlighted acute pancreatitis as a known, infrequent but serious risk in a Drug Safety Update issued in January 2026; it's worth knowing about, without letting it overshadow the overall safety profile for suitable patients. Gallbladder symptoms, signs of dehydration from severe GI illness, and any allergic reaction also need prompt medical review.
Injection-site discomfort is usually minor and temporary. Whether the injection hurts is one of the questions our prescribers hear most often, in practice, the pen is designed so the needle is small and the mechanism does most of the work. Rotating sites between the abdomen, thigh and upper arm helps prevent local reactions. Any suspected side effect can be reported directly to the MHRA's Yellow Card scheme.
The injection doesn't burn fat directly, accelerate your metabolism in the stimulant sense, or work independently of what you eat. It creates the hormonal conditions in which eating less becomes easier, the rest is still down to the choices that become genuinely easier to make. It also doesn't continue working after you stop: the appetite effects reverse as the medicine clears your system, which is why ongoing clinical review and building sustainable habits alongside treatment matters.
It isn't suitable for everyone. Pregnancy, breastfeeding, and trying to conceive are contraindications; the medicines aren't licensed for under-18s; and certain conditions, including a history of medullary thyroid cancer or pancreatitis, require careful prescriber assessment. A prescriber considers your full picture, not just your BMI. If you'd like to explore whether treatment is appropriate for you, our free consultation is reviewed the same day by a named, GPhC-registered prescriber. Our weight loss treatment page sets out what's available and how the process works, including what arrives: a tracked DPD parcel, plain packaging, with the pen inside exactly as described.
Questions about different names for the same medicines, or the difference between the injections and the newer tablet, are covered in detail on the weight loss injection names page. For the cost side of things, the page on weight loss injection costs explains what private pricing typically covers and what to look for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.